Mucosal immunity Currently licensed SARS-CoV-2 vaccines are all delivered parenterally via intramuscular injection, which leads to some limitations for vaccine roll-out and potentially for protective efficacy (Table 1)
Some patients report changes in comfort, mobility, or recovery within the first few weeks, but results vary and should not replace diagnosis, imaging, rehab, or medical treatment
Decision matrix Safety considerations researchers should know Both compounds are newer than established GLP-1 agonists , which means their long-term safety profiles are still being characterized
Product Specifications For Research Use Only
10.3390/toxins8060173 33 FranzCMAPHuchM.AbriouelH.HolzapfelW.GlvezA
Side Effects: Cyanocobalamin is generally well-tolerated, but some patients might experience side effects, including